Abstract
The role of the A3 haplotype and soluble endothelial protein C receptor (sEPCR) plasma levels in predisposing the carriers of two peculiar dysfunctional protein C (PC) variants (PC Arg-1→Cys and PC Arg-1→Leu, also known as PC Padua 2 and PC Padua 3, respectively) to venous thromboembolism (VTE) has been evaluated. The levels of sEPCR have been assessed in family members during 6 years of follow-up and correlated to the presence of the A3 haplotype. Individuals who carried both a dysfunctional PC and the A3 haplotype and presenting with high levels of sEPCR experienced severe VTE at young age. The increased plasma levels of sEPCR were not related to excessive thrombin generation. Carriers of the A3 haplotype showed levels of sEPCR above 135 ng/ml (80th percentile of the distribution in healthy subjects), which remained elevated during the follow-up. In non-carriers of the A3 haplotype, sEPCR levels remained persistently around 100 ng/ml or lower. In conclusion, we have observed that elevated sEPCR plasma levels and the concomitant presence of the A3 haplotype of EPCR gene are associated with severe thrombotic manifestations in carriers of two dysfunctional PC variants. Whether high plasma levels of sEPCR and/or the presence of the A3 haplotype increase the risk of thrombosis in carriers of other PC defects or thrombophilic conditions remains to be clarified.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
